RAP 0.00% 20.5¢ resapp health limited

Ann: Results of Scheme Meeting, page-20

  1. 709 Posts.
    lightbulb Created with Sketch. 277
    Looks like the cross promotion guidelines are out the window now!!

    When considering MedTech, I think HMD worth a look at IMO. Connections in common with RAP clinical developers and early backers.
    (Disclosure I have a bundle)
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.